Regenera Pharma Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Out of Business

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Out of Business

Regenera Pharma General Information

Description

Operator of a clinical-stage pharmaceutical company intended to develop drugs and other related pharmaceutical products. The company's drugs are used to treat neurological damage caused by pathological conditions and regenerating damaged tissues, enabling patients to avail drugs for neurodegenerative diseases and chronic non-healing wounds, providing patients to restore neural function.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Corporate Office
  • Einstein 18, Science Park
  • Ness Ziona
  • Israel

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Regenera Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Out of Business 20-Apr-2021 000.00 Completed Out of Business
5. Later Stage VC (Series B) 02-Jan-2018 000.00 000.00 000.00 Completed Generating Revenue
4. Secondary Transaction - Private 00.000 Completed Generating Revenue
3. Later Stage VC 17-Feb-2015 00.000 00.000 000.00 Completed Generating Revenue
2. Angel (individual) 01-Jan-2012 $400K $1.02M Completed Startup
1. Angel (individual) 01-Jan-2011 $625K $625K Completed Startup
To view Regenera Pharma’s complete valuation and funding history, request access »

Regenera Pharma Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Preferred B2 0,000,000 00.000000 00.00 00.00 00 00.00 0.000
Preferred B1 000,000 00.000000 00.00 00.00 00 00.00 00.00
Preferred B 0,000,000 00.000000 00.0 00.0 00 00.0 00.000
Preferred A1 1,412,071 $0.010000 $5.75 $5.75 1x $5.75 2.78%
Preferred A 1,412,071 $0.010000 $4.6 $4.6 1x $4.6 21.24%
To view Regenera Pharma’s complete cap table history, request access »

Regenera Pharma Patents

Regenera Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3509699-A1 Compositions comprising triterpenoids and uses thereof for treating optic neuropathy Pending 08-Sep-2016 0000000000
US-20190224217-A1 Compositions comprising triterpenoids and uses thereof for treating optic neuropathy Active 08-Sep-2016 0000000000
US-11207333-B2 Compositions comprising triterpenoids and uses thereof for treating optic neuropathy Active 08-Sep-2016 0000000000 00
US-10751347-B2 Compositions comprising acidic extracts of mastic gum and uses thereof for treating optic neuropathy Active 08-Sep-2016 000000000 00
EP-3509577-A1 Compositions comprising acidic extracts of mastic gum and uses thereof for treating optic neuropathy Pending 08-Sep-2016 A61K31/568
To view Regenera Pharma’s complete patent history, request access »

Regenera Pharma Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Regenera Pharma FAQs

  • When was Regenera Pharma founded?

    Regenera Pharma was founded in 2008.

  • Who is the founder of Regenera Pharma?

    Zadik Hazan MD and Yitzhak Peterburg Ph.D are the founders of Regenera Pharma.

  • Where is Regenera Pharma headquartered?

    Regenera Pharma is headquartered in Ness Ziona, Israel.

  • What is the size of Regenera Pharma?

    Regenera Pharma has 6 total employees.

  • What industry is Regenera Pharma in?

    Regenera Pharma’s primary industry is Biotechnology.

  • Is Regenera Pharma a private or public company?

    Regenera Pharma is a Private company.

  • What is Regenera Pharma’s current revenue?

    The current revenue for Regenera Pharma is 000000.

  • How much funding has Regenera Pharma raised over time?

    Regenera Pharma has raised $24.7M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »